Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
Access Resources
About
This one-page infographic provides guidance on using nirsevimab (Beyfortus) to prevent severe RSV in infants and toddlers. It addresses high-risk conditions in children, as well as dosing information. Dosage depends on age, weight, and health conditions. Infants born during different months have specific guidelines for receiving doses. High-risk children aged 8-19 months entering their second RSV season need a 200mg dose before the season starts.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.